Nippon India Pharma Fund-Growth Plan-Growth Option
(Erstwhile Reliance Pharma Fund-Growth Plan-Growth Option)
| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 01-06-2004 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.15% As on (31-01-2020) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 2,421.07 Cr As on (29-02-2020) |
| Turn over: 16% | Exit Load: For units in excess of 10% of the investment,1% will be charged for redemption within 365 days |
164.7321
5.37 (3.262%)
19.33%
S&P BSE Healthcare TRI 10.76%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Current Asset Allocation (%)
Indicators
| Volatility | 15.77 |
| Sharp Ratio | -0.02 |
| Alpha | 1.92 |
| Beta | 0.84 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | 9.24 | 9.28 | 6.73 | 2.42 | 12.89 |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | 16.86 | - | - | - | - |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | 15.92 | - | - | - | - |
| Mirae Asset Healthcare Fund -Regular Growth | 20-07-2018 | 15.03 | - | - | - | - |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | 14.43 | 9.56 | 4.19 | - | - |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 05-07-2018 | 9.98 | - | - | - | - |
| UTI Healthcare Fund - Regular Plan - Growth Option | 01-08-2005 | 7.97 | 4.66 | 1.11 | -2.81 | 10.34 |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 14-07-1999 | 7.78 | 3.83 | -1.81 | -3.23 | 13.01 |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | - | - | - | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
13.49%
Others
-0.01%
Large Cap
53.7%
Mid Cap
32.82%
Scheme Documents
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
